Fecal transplant trial provides hope for liver disease patients
The UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and fight antimicrobial resistance.
Jun 22, 2023
0
1
The UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and fight antimicrobial resistance.
Jun 22, 2023
0
1
In most people, any liver damage that might occur from drinking alcohol is reversible. However, in 25 to 30 percent of alcoholics what begins as accumulation of fat in the liver progresses to inflammation, fibrosis and ultimately ...
Mar 30, 2015
0
9
(HealthDay)—Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17 years, the U.S. Food and Drug Administration announced yesterday.
May 1, 2019
0
1
A new study from the Virginia Commonwealth University School of Medicine has identified molecular changes responsible for abnormal cholesterol production and metabolism in the livers of patients with a common liver condition, ...
Jun 7, 2012
0
0
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care (IQWiG) ...
Dec 10, 2014
0
0
Millions of people throughout the world are infected with hepatitis C virus (HCV), which can lead to cirrhosis of the liver and cancer. Directly acting antiviral agents inhibit viral proteins and have been used to successfully ...
Jul 1, 2014
0
0
A smartphone app can quickly screen for cognitive dysfunction often found in patients with cirrhosis, according to a new Virginia Commonwealth University study. The cognitive dysfunction, known as minimal hepatic encephalopathy ...
Sep 18, 2013
0
0
(HealthDay)—Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through ...
Oct 1, 2019
0
2
In a recent issue of the journal Nature, Virginia Commonwealth University School of Medicine associate professor Jasmohan S. Bajaj, M.D., provides new data to reinterpret conclusions from a July 2014 Nature journal study ...
Oct 5, 2015
0
19
Results presented today at The International Liver Congress 2015 show that the use of the fixed-dose combination of ledipasvir/sofosbuvir (LDV/SOF) in combination with ribavirin (RBV) was well tolerated and demonstrated high ...
Apr 23, 2015
0
6